For comparing GLP-1RAs with insulins in patients with T2D, the study population included 1 093 728 patients with T2D who had no prior diagnosis of any OAC and were prescribed GLP-1RAs or insulins but not both between March 2005 and November 2018
With the number of diabetes cases continuing to grow each year across all regions of the world, there is heightened awareness about the importance of glucose control in diabetes management and the need for advanced therapeutic options
Dose de 5 mg: a perda de peso mdia foi de 15,0%
Hubalewska-Dydejczyk A, Duntas L, Gilis-Januszewska A
Relating to its high burden of comorbidities, HFpEF syndromes are known to be quite heterogeneous, with multiple distinct phenotypes having been proposed [5,6,7]
Some resolve with discontinuation